Opens in a new tab

NJOY Netherlands v Juul Labs International (CFI, 28 February 2025)

Date28 February 2025
CourtCFI
DivisionParis (FR) Central Division - Seat
Type of actionRevocation Action
Case number(s)UPC_CFI_312/2023
Registry reference571761/2023 · ORD_10060/2025571761/2023 · UPC_CFI_312/2023
PartiesNJOY Netherlands B.V. / v / Juul Labs International Inc.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By decision of 28 February 2025, the Paris Central Division, ruling on NJOY Netherlands’ revocation action against Juul Labs International’s EP 3 504 989 (“Vaporization device systems”), holds that claim 1 as granted contains added matter, but maintains the patent as amended by Auxiliary Request I filed on 22 July 2024, for Belgium, France, Germany, Italy, the Netherlands, Portugal and Sweden. Each party bears its own costs. The decision shows a strict application of the bar on intermediate generalisation: a feature taken from an embodiment cannot be isolated where it is intrinsically linked to another element, but the proprietor may cure the defect by reintroducing only the functionally linked element, without importing the whole figure.

Facts and procedure

The revocation action was filed on 15 September 2023. Juul’s preliminary objection was rejected, and that rejection was upheld by the Court of Appeal. The patent derives from a divisional application filed on 15 February 2019 from the international application published as WO 2015/100361, oppositions were pending at the EPO when the action was filed, NJOY not being a party to them. Juul reduced its 55 auxiliary requests to eight, which the division admitted (paragraph 9.3). NJOY relied on added matter, lack of novelty and lack of inventive step, in particular over Chen (CN 101843368 A) and Cohen (US 2011/0036346 A1).

The applicable law

The grounds for revocation fall under Art. 138(1)(a) and (c) EPC, read with Arts. 52, 54, 56, 76(1) and 123(2) EPC. Claims are construed under Art. 69 EPC and its Protocol (paragraphs 7.2 to 7.6). Added matter is assessed by asking what is directly and unambiguously derivable from the application as filed (paragraph 8.2). The procedure is front-loaded: the claimant must present its case in the statement for revocation, although a generous standard applies to replies to the other side’s arguments (paragraphs 5.3 and 5.4).

Question

Does claim 1, which requires a channel air inlet to be left exposed, have a basis in the application as filed without the feature of the notch in the device body, and is Auxiliary Request I allowable, novel and inventive?

Decision

The division holds that the basis relied on by Juul, claim 159 and paragraph [00170] of WO 2015/100361, is insufficient: claim 159 contains no notch, and paragraph [00170] and Figure 14 intrinsically link the exposure of the air inlet to the notch, whereas granted claim 1 separates them (paragraphs 8.5 to 8.13). The argument that the notch may be varied is rejected and the patent cannot be maintained as granted (paragraphs 8.15 and 8.16). Auxiliary Request I, which specifies that the size of the air inlet is defined by the configuration of the notch, is allowable: the other elements of Figure 14 (battery, circuit board, sensor) are not linked to the air inlet, and “configuration” covers size and shape without requiring any particular notch (paragraphs 9.4 to 9.16). It is novel over Chen, whose semicircular holes are not a notch exposing a separate inlet, and over Cohen (paragraphs 9.17 to 9.37), and NJOY fails to establish obviousness (paragraphs 9.38 to 9.41). On procedure, the division admits the Hajaligol expert declaration and the rejoinder, but excludes pages 4 to 14 of NJOY’s submission of 22 April 2024 and Juul’s submission of 31 May 2024 (paragraphs 5.6 to 5.17). Each party bears its own costs under Art. 69(2) UPCA and Rule 118.5 (paragraph 11.1).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts. 69(2), 73(1) and 82
Rules of Procedure
Rules 9.1, 9.2, 19.1(a), 32.3, 36, 43.3, 44, 48, 52, 55, 58, 118.5, 220.1(a) and 224.1(a)
European Patent Convention
Arts. 52, 54, 56, 69, 76, 84, 123 and 138
Case law cited
NanoString v 10x Genomics, Court of Appeal, 26 February 2024, VusionGroup v Hanshow, Court of Appeal, 13 May 2024, Umedwings v Abbott Diabetes Care, The Hague Local Division, 19 June 2024

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Revocation action.

Publications by Matthieu Dhenne: G 1/25, Take Three: Anything You Leave in the Description May Be Used Against You (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_312/2023 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Revocation Action
Outcome (Dhenne Avocats summary)
La division centrale, section de Paris, juge que la revendication 1 telle que délivrée étend l’objet de la demande initiale, mais maintient le brevet de Juul sous la forme de la requête subsidiaire I, nouvelle et inventive. Chaque partie conserve ses frais.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 504 989Mentioned in the analysis (role not qualified)not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.